Douglas Bingham Fox, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nucleotides | 1 | 2020 | 454 | 0.580 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 373 | 0.570 |
Why?
|
Neoplastic Cells, Circulating | 3 | 2021 | 946 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2021 | 9277 | 0.200 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2557 | 0.180 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 5305 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2020 | 736 | 0.140 |
Why?
|
Oxidation-Reduction | 2 | 2020 | 2230 | 0.130 |
Why?
|
Caprylates | 1 | 2016 | 115 | 0.130 |
Why?
|
Breast Neoplasms | 5 | 2021 | 21012 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8545 | 0.120 |
Why?
|
Cell Death | 1 | 2020 | 1677 | 0.120 |
Why?
|
Cell Line, Tumor | 6 | 2020 | 16979 | 0.110 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 205 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.110 |
Why?
|
Carbon | 1 | 2016 | 665 | 0.110 |
Why?
|
Down-Regulation | 1 | 2020 | 2918 | 0.100 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2141 | 0.100 |
Why?
|
Gene Silencing | 1 | 2018 | 1509 | 0.100 |
Why?
|
Wnt Proteins | 1 | 2015 | 718 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2015 | 1079 | 0.080 |
Why?
|
Homeostasis | 1 | 2020 | 3321 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2803 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1902 | 0.080 |
Why?
|
Glucose | 1 | 2019 | 4347 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1410 | 0.070 |
Why?
|
Histones | 1 | 2016 | 2580 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7595 | 0.070 |
Why?
|
Mice, Nude | 2 | 2020 | 3614 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3602 | 0.040 |
Why?
|
Mice | 4 | 2020 | 81509 | 0.040 |
Why?
|
4-Chloro-7-nitrobenzofurazan | 1 | 2019 | 21 | 0.040 |
Why?
|
Signal Transduction | 2 | 2020 | 23441 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5665 | 0.040 |
Why?
|
Animals | 6 | 2020 | 168441 | 0.040 |
Why?
|
Doxycycline | 1 | 2020 | 344 | 0.040 |
Why?
|
Histone Deacetylase 2 | 1 | 2018 | 72 | 0.040 |
Why?
|
Deoxyglucose | 1 | 2019 | 333 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2019 | 295 | 0.040 |
Why?
|
Histone Deacetylase 1 | 1 | 2018 | 133 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2019 | 271 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 582 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5302 | 0.030 |
Why?
|
Single-Cell Analysis | 2 | 2020 | 2449 | 0.030 |
Why?
|
Acetyl Coenzyme A | 1 | 2016 | 74 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 570 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2019 | 647 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2019 | 1561 | 0.030 |
Why?
|
Genotype | 2 | 2021 | 13009 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1055 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11118 | 0.030 |
Why?
|
Female | 6 | 2021 | 392581 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 774 | 0.020 |
Why?
|
RNA Splicing | 1 | 2015 | 918 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 971 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1370 | 0.020 |
Why?
|
Humans | 8 | 2021 | 761423 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1371 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2020 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1770 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13449 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 30045 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5794 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10441 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4510 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16606 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9418 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11902 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54415 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13337 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13637 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 58956 | 0.010 |
Why?
|
Male | 2 | 2015 | 360736 | 0.000 |
Why?
|
Aged | 1 | 2015 | 169235 | 0.000 |
Why?
|
Middle Aged | 1 | 2015 | 220826 | 0.000 |
Why?
|
Adult | 1 | 2015 | 221148 | 0.000 |
Why?
|